Risk of Parkinson’s Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational Studies
Journal of Neurodegenerative Diseases · 2016
DOI: 10.1155/2016/5780809 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurodegenerative Diseases, 2016. Verfasst von Amarnath Mullapudi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab 160062, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Antihypertensive agents have been shown to inhibit oxidative stress and inflammatory response and thus neuroprotection in Parkinson’s disease (PD). Epidemiological evidence suggests inconsistency between use of antihypertensives and risk of PD. This study is aimed to examine the association between antihypertensive use and risk of PD.
Methods
Literature search in PubMed, EMBASE, and PsycINFO database was undertaken through February 2012 looking for observational studies evaluating the association between antihypertensive drug use and risk of PD. Before meta-analysis, the studies were evaluated for publication bias and heterogeneity. Pooled relative risk (RR) estimates and 95% confidence intervals (CIs) were calculated using random-effects model (DerSimonian and Laird method). Subgroup analyses and sensitivity analysis were also performed.
Results
Seven relevant studies including a total of 28,32,991 subjects were included. Pooled RR of overall use of antihypertensive agents was found to be 0.95 (95% CI 0.84–1.05). A significant reduction in the risk of PD was observed among users of calcium channel blockers (RR 0.82, 95% CI 0.71–0.93). Significant heterogeneity ( I 2 = 76.2%) but no publication bias was observed.
Conclusions
Overall use of antihypertensive agents showed no significant association with the risk of PD. CCBs provided significant protective role. However, studies with large sample size and dose relationships are required to strengthen our hypothesis.
Autor:innen und Institutionen
- Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, SAS Nagar, Punjab 160062, India.
ORCID-Profile: Dipika Bansal
Zitieren
APA
Mullapudi, A., Gudala, K., Boya, C. S., & Bansal, D. (2016). Risk of Parkinson’s Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational Studies. Journal of Neurodegenerative Diseases. https://doi.org/10.1155/2016/5780809
Vancouver
Mullapudi A, Gudala K, Boya CS, Bansal D. Risk of Parkinson’s Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational Studies. Journal of Neurodegenerative Diseases. 2016. doi:10.1155/2016/5780809
BibTeX
@article{Mullapudi2016,
author = {Mullapudi, Amarnath and Gudala, Kapil and Boya, Chandra Sekhar and Bansal, Dipika},
title = {Risk of Parkinson’s Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational Studies},
journal = {Journal of Neurodegenerative Diseases},
year = {2016},
doi = {10.1155/2016/5780809}
}
EUVIMED